The association of genetic factors with serum calretinin levels in asbestos-related diseases
Article Category: Research Article
Published Online: Nov 30, 2023
Page range: 473 - 486
Received: Oct 19, 2023
Accepted: Oct 31, 2023
DOI: https://doi.org/10.2478/raon-2023-0061
Keywords
© 2023 Cita Zupanc et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Background
Asbestos exposure is associated with different asbestos-related diseases, including malignant mesothelioma (MM). MM diagnosis is confirmed with immunohistochemical analysis of several markers, including calretinin. Increased circulating calretinin was also observed in MM. The aim of the study was to determine if
Subjects and methods
The study included 288 MM patients and 616 occupationally asbestos-exposed subjects without MM (153 with asbestosis, 380 with pleural plaques and 83 without asbestos-related disease). Subjects were genotyped for seven polymorphisms in
Results
Carriers of at least one polymorphic
Conclusions
The results of presented study suggest that genetic variability could influence serum calretinin levels. These findings could contribute to a better understanding of calretinin regulation and potentially to earlier MM diagnosis.